MLchartDataset catalogue

AMD 3100

Term · Oncology and biomedicine · MLC-T-ONC-000438

A drug used with granulocyte colony-stimulating factor before an autologous stem cell transplant in patients with non-Hodgkin lymphoma or multiple myeloma. It is also being studied in the treatment of other types of cancer. AMD 3100 helps move stem cells from the bone marrow to the blood so they can be collected, stored, and then given back to the patient. AMD 3100 is a type of hematopoietic stem cell mobilizer. Also called Mozobil and plerixafor.

Table 1. Record
IdentifierMLC-T-ONC-000438
FieldOncology and biomedicine
SynonymsMozobil; plerixafor
ReferencesNCI Dictionary of Cancer Terms
Record as JSON 
{
  "id": "MLC-T-ONC-000438",
  "term": "AMD 3100",
  "field": "Oncology and biomedicine",
  "definition": "A drug used with granulocyte colony-stimulating factor before an autologous stem cell transplant in patients with non-Hodgkin lymphoma or multiple myeloma. It is also being studied in the treatment of other types of cancer. AMD 3100 helps move stem cells from the bone marrow to the blood so they can be collected, stored, and then given back to the patient. AMD 3100 is a type of hematopoietic stem cell mobilizer. Also called Mozobil and plerixafor.",
  "synonyms": [
    "Mozobil",
    "plerixafor"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/amd-3100/"
}

Record 945 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.